M2 Archive: Preview
You haven't logged in. If you have archive credits in your account, please log in now to use them. If not, you can buy credits in our shopping area.
S&P cuts targets on two Danish pharma stocks
3 March 2010 - Standard & Poor's (S&P) has maintained its "buy" rating on Danish pharma company H Lundbeck A/S (CPH: LUN) and allergy-vaccine maker ALK-Abello A/S (CPH: ALK B), while cutting their share price targets.The target on Lundbeck, which is due to release its financial report for...
If you want to view the full text, you must first purchase archive credits.
Return to Archives
New Search